These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 24272847)
1. Potentiation of enteral absorption of human interferon alpha and selective transfer into lymphatics in rats. Yoshikawa H; Takada K; Satoh Y; Naruse N; Muranishi S Pharm Res; 1985 Sep; 2(5):249-50. PubMed ID: 24272847 [TBL] [Abstract][Full Text] [Related]
2. A method to potentiate enteral absorption of interferon and selective delivery into lymphatics. Yoshikawa H; Takada K; Muranishi S; Satoh Y; Naruse N J Pharmacobiodyn; 1984 Jan; 7(1):59-62. PubMed ID: 6726613 [TBL] [Abstract][Full Text] [Related]
3. Development of Interferon Suppositories. I. Enhanced Rectal Absorption of Human Fibroblast Interferon by Fusogenic Lipid via Lymphotropic Delivery in Rats. Yoshikawa H; Takada K; Satoh Y; Naruse N; Muranishi S Pharm Res; 1986 Apr; 3(2):116-7. PubMed ID: 24271471 [TBL] [Abstract][Full Text] [Related]
4. The mode of enhanced enteral absorption of macromolecules by lipid-surfactant mixed micelles. I. Masuda Y; Yoshikawa H; Takada K; Muranishi S J Pharmacobiodyn; 1986 Oct; 9(10):793-8. PubMed ID: 3820056 [TBL] [Abstract][Full Text] [Related]
5. Promotion of the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles. Takada K; Shibata N; Yoshimura H; Masuda Y; Yoshikawa H; Muranishi S; Oka T J Pharmacobiodyn; 1985 Apr; 8(4):320-3. PubMed ID: 4032221 [TBL] [Abstract][Full Text] [Related]
6. Comparison of disappearance from blood and lymphatic delivery of human fibroblast interferon in rat by different administration routes. Yoshikawa H; Satoh Y; Naruse N; Takada K; Muranishi S J Pharmacobiodyn; 1985 Mar; 8(3):206-10. PubMed ID: 4009412 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of antitumor effect of bleomycin by lipid-surfactant mixed micelles. I. In vivo and tumor-neutralizing activity against mouse Ehrlich ascites tumor and rat ascites hepatoma AH66. Yoshikawa H; Takada K; Muranishi S J Pharmacobiodyn; 1985 Apr; 8(4):305-10. PubMed ID: 2411907 [TBL] [Abstract][Full Text] [Related]
8. Modification of liposomes by addition of HCO60. I. Targeting of liposomes to liver by addition of HCO60 to liposomes. Kato Y; Watanabe K; Hosokawa T; Hayakawa E; Ito K Biol Pharm Bull; 1993 Oct; 16(10):960-4. PubMed ID: 8287045 [TBL] [Abstract][Full Text] [Related]
9. Investigation of the release behavior of diethylhexyl phthalate from polyvinyl chloride tubing for intravenous administration based on HCO60. Hanawa T; Endoh N; Kazuno F; Suzuki M; Kobayashi D; Tanaka M; Kawano K; Morimoto Y; Nakajima S; Oguchi T Int J Pharm; 2003 Nov; 267(1-2):141-9. PubMed ID: 14602392 [TBL] [Abstract][Full Text] [Related]
10. Studies on the promoting effect of lipid-surfactant mixed micelles (MM) on intestinal absorption of colloidal particles. Dependence on particle size and administration site. Fukui H; Murakami M; Yoshikawa H; Takada K; Muranishi S J Pharmacobiodyn; 1987 Jun; 10(6):236-42. PubMed ID: 3668782 [TBL] [Abstract][Full Text] [Related]
11. Absorption of new HIV-1 protease inhibitor, KNI-272, after intraduodenal and intragastric administrations to rats: effect of solvent. Sugahara M; Kiriyama A; Hamada Y; Kiso Y; Takada K Biopharm Drug Dispos; 1995 May; 16(4):269-77. PubMed ID: 7548776 [TBL] [Abstract][Full Text] [Related]
12. Potentiation of the antiviral and anticellular activities of interferons by mixtures of HuIFN-gamma and HuIFN-alpha or HuIFN-beta. Oleszak E; Stewart WE J Interferon Res; 1985; 5(2):361-71. PubMed ID: 2989390 [TBL] [Abstract][Full Text] [Related]
13. Effect of oxyethylene moieties in hydrogenated castor oil on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with hydrogenated castor oil and soybean oil in rats. Ueda K; Yamazaki Y; Noto H; Teshima Y; Yamashita C; Sakaeda T; Iwakawa S J Drug Target; 2003 Jan; 11(1):37-43. PubMed ID: 12852439 [TBL] [Abstract][Full Text] [Related]
14. Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. I. Effects of ionic strength, adjuvant composition, and lipid structure on the nasal absorption of [D-Arg2]kyotorphin. Tengamnuay P; Mitra AK Pharm Res; 1990 Feb; 7(2):127-33. PubMed ID: 2308892 [TBL] [Abstract][Full Text] [Related]
15. Size characteristics of human leucocyte interferon under reducing and non-reducing conditions. Braude IA; Lin LS; Stewart WE Biochem J; 1981 Mar; 193(3):947-51. PubMed ID: 6171256 [TBL] [Abstract][Full Text] [Related]
16. Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various absorption enhancers and their pulmonary toxicity in rats. Yamamoto A; Okumura S; Fukuda Y; Fukui M; Takahashi K; Muranishi S J Pharm Sci; 1997 Oct; 86(10):1144-7. PubMed ID: 9344172 [TBL] [Abstract][Full Text] [Related]
17. Synergism between human tumor necrosis factor and human interferon-alpha: effects on cells in culture. Orita K; Ando S; Kurimoto M Acta Med Okayama; 1987 Aug; 41(4):155-60. PubMed ID: 3661240 [TBL] [Abstract][Full Text] [Related]
18. An interferon analogue, [Ala 30,32,33]HuIFN-alpha 2, acting as a HuIFN-alpha 2 antagonist on bovine cells. Marcucci F; De Maeyer E Biochem Biophys Res Commun; 1986 Feb; 134(3):1412-8. PubMed ID: 3004491 [TBL] [Abstract][Full Text] [Related]
19. Effects of hyperthermia on the in vitro antiproliferative activities of HuIFN-alpha, HuIFN-beta, and rHuIFN-gamma employed separately and in combination. Fleischmann CM; Fleischmann WR J Biol Regul Homeost Agents; 1988; 2(3):145-54. PubMed ID: 3151143 [TBL] [Abstract][Full Text] [Related]
20. The human interferon alpha-receptor protein confers differential responses to human interferon-beta versus interferon-alpha subtypes in mouse and hamster cell transfectants. Abramovich C; Chebath J; Revel M Cytokine; 1994 Jul; 6(4):414-24. PubMed ID: 7948750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]